Patrys Limited has released a press release.
Ethics Approval Secured for Phase 1A Clinical Trial
Earlier from Patrys
- Investor Presentation - TechKnow Invest Roadshow
- Appendix 4C - Quarterly - 30 June 2026
- Patrys Secures 50% Revenue Share in IP Commercialisation
- Patrys advances RLS-2202 toward Phase 1 Clinical Trial